Related Experiment Videos
Ultrastructural studies in 4-aminopyrazolopyrimidine (4-APP)-induced fatty liver
Abstract:
Ultrastructural alterations of 4-aminopyrazolopyrimidine (4-APP)-induced fatty liver were studied. Light microscopically, liver sections after 3 to 5 days of 4-APP administration demonstrated more extensive fatty changes and highly osmiophilic lipid droplets were mainly observed in the portal zones of the lobules. The most striking ultrastructural alterations were seen in the Golgi complexes and rough endoplasmic reticulum. Golgi complexes were markedly dilated and osmiophilic vesicles were noted near the Golgi complexes. In the rough endoplasmic reticulum, dilatation of cisternae, loss of the parallel arrangement and dilated vesicles, most of which contained diminished numbers of ribosomes, were also seen. In addition, degranulation of rough endoplasmic reticulum was observed. However, no remarkable changes were noted in the mitochondria. Based on these findings, the functional state of the organellae concerned was discussed.
Insights
Ultrastructural examination revealed 4-aminopyrazolopyrimidine (4-APP) induces significant fatty liver changes, primarily affecting Golgi complexes and rough endoplasmic reticulum. These organelles show dilation and degranulation, impacting cellular function.
Area of Science:
- Hepatology
- Cell Biology
- Toxicology
Background:
- Fatty liver disease is a growing health concern.
- Understanding the cellular mechanisms of drug-induced liver injury is crucial.
- 4-aminopyrazolopyrimidine (4-APP) is a compound known to induce liver alterations.
Purpose of the Study:
- To investigate the ultrastructural changes in the liver induced by 4-aminopyrazolopyrimidine (4-APP).
- To identify specific organelle alterations associated with 4-APP-induced fatty liver.
Main Methods:
- Light microscopy was used to assess overall fatty changes.
- Transmission electron microscopy was employed to examine ultrastructural details of liver cells.
- Analysis focused on organelles such as Golgi complexes and endoplasmic reticulum.
Main Results:
- 4-APP administration led to significant fatty changes in liver lobules, concentrated in portal zones.
- Striking alterations were observed in Golgi complexes (marked dilation, osmiophilic vesicles) and rough endoplasmic reticulum (cisternae dilation, loss of ribosome attachment, degranulation).
- Mitochondria showed no remarkable changes.
Conclusions:
- 4-APP induces significant ultrastructural damage to the Golgi complex and rough endoplasmic reticulum, contributing to fatty liver.
- The observed organelle dysfunctions likely play a key role in the pathogenesis of 4-APP-induced hepatotoxicity.
- Further research is needed to elucidate the precise functional consequences of these alterations.